Lucidumol A
Lucidumol A is a bioactive small molecule exhibiting aldose reductase inhibitory activity (IC50 = 19.1 μM) and dose-dependent cytotoxic effects against human carcinoma cell lines, including Caco-2, HepG2, and HeLa, with LC50 values ranging from 20.87 to 84.36 μM. This compound is a candidate for research in diabetic complications and oncology, suitable for in vitro enzymatic and cytotoxicity studies.
Product Specifications
CAS Number
217476-73-8
Smiles
C[C@]12C3=C ([C@]4 (C) [C@@] (CC3=O) (C (C) (C) C (=O) CC4) [H]) CC[C@]1 (C) [C@@] ([C@@H] (CC[C@@H] (C (C) (C) O) O) C) (CC2) [H]
Molecular Formula
C30H48O4
Molecular Weight
472.7
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6353963-01 0.2 mL
TBC1D8, CT (TBC1D8, VRP, TBC1 domain family member 8, AD 3, Vascular Rab-GAP/TBC-containing protein) (AP)
Sign In for Pricing
View Details MBS6353963-02 5x 0.2 mL
TBC1D8, CT (TBC1D8, VRP, TBC1 domain family member 8, AD 3, Vascular Rab-GAP/TBC-containing protein) (AP)
Sign In for Pricing
View Details RA11606-01 50 µL
Lamin B1 Monoclonal Antibody (7C11), Cy5 Conjugated
Sign In for Pricing
View Details RA11606-02 100 µL
Lamin B1 Monoclonal Antibody (7C11), Cy5 Conjugated
Sign In for Pricing
View Details